Wof agent is used to prevent hemorrhagic cystitis caused by cyclophosphamide and ifosfamide
**Core Concept**
Wof agents are a class of medications used to prevent hemorrhagic cystitis, a condition characterized by bleeding from the bladder, often caused by chemotherapy agents like cyclophosphamide and ifosfamide. This condition arises due to the urotoxic metabolite acrolein, which is produced during the metabolism of these chemotherapy agents.
**Why the Correct Answer is Right**
Mesna (sodium 2-mercaptoethanesulfonate) is used to prevent hemorrhagic cystitis by binding to the urotoxic metabolite acrolein, thereby inhibiting its action on the bladder mucosa. This mechanism of action is specific to mesna, which is a sulfhydryl-containing compound that can effectively neutralize acrolein and prevent bladder damage.
**Why Each Wrong Option is Incorrect**
**Option A:** Sodium bicarbonate is used to alkalize the urine and reduce the risk of nephrotoxicity, but it does not have a specific mechanism for preventing hemorrhagic cystitis caused by cyclophosphamide and ifosfamide.
**Option B:** Folinic acid is used to counteract the toxic effects of methotrexate and other folate antagonists, but it is not used to prevent hemorrhagic cystitis.
**Option C:** Amifostine is a cytoprotective agent that can reduce the risk of nephrotoxicity and ototoxicity associated with certain chemotherapy agents, but it is not specifically used to prevent hemorrhagic cystitis.
**Clinical Pearl / High-Yield Fact**
Mesna should be administered concurrently with cyclophosphamide and ifosfamide to prevent hemorrhagic cystitis, and the dose should be adjusted based on the patient's renal function and the total dose of the chemotherapy agent.
**Correct Answer:** D. Mesna (sodium 2-mercaptoethanesulfonate)